Back to search

The University of Edinburgh

Therapeutic potential of mesenchymal stromal cells for infected fracture non-union

Abstract

dc:description.abstract

Non-union is a well-recognised complication after open fractures. It has a devastating impact on patient quality of life and can result in limb loss. Fifty percent of open military extremity trauma returning from operations overseas developed non-union. This is twice that reported in the civilian literature. Aetiology of non-union is multi-factorial with infection reported as a major contributory factor. Mesenchymal Stromal Cells (MSC) are multi-progenitor cells found in bone marrow, periosteum, and adipose tissue, which can differentiate into bone, cartilage, adipose tissue, tendon, and muscle. Percutaneous administration of MSCs have been shown to prevent fracture non-union in an atrophic non-union animal model. MSCs secrete bioactive molecules with immunomodulatory potential and have demonstrated beneficial effects in bacterial induced sepsis and biofilm animal models. The role of MSCs in treating infected fracture non-union has not been previously described. The aim of this thesis was to: 1)Investigate the in-vitro effects of human bone marrow derived MSCs on the growth of Staphylococcus aureus (S. aureus), the most common organism isolated in orthopaedic related infections 2)To explore and identify potential modes or mechanisms of action for how MSCs may be exerting their antimicrobial effect 3)Establish an in-vivo model of infected fracture non-union managed with external fixation which allowed real time monitoring of infection which could be used to evaluate potential therapeutic strategies and allow translation towards clinical trials. This thesis demonstrated that both the MSCs and their conditioned media reduced S. aureus growth in-vitro. Direct observation of the MSCs identified that the cells changed their morphology in the presence of bacteria. This observation was quantified using Electric Cell-substrate Impedance Sensing, a method for monitoring cell behaviour in culture. Studies investigating potential mode and mechanisms of action for MSCs exerting their antimicrobial effect identified relatively increased presence of following cytokines: Leptin, Myeloperoxidase PDGF-AB/BB and reduced presence of IL-3 and IL-16 in growth medium from MSCs co-cultured with S. aureus. Also, the osteogenic potential of MSCs was not down regulated when exposed to S. aureus. An infected fracture non-union animal model stabilised using an external fixator was established. This model demonstrated radiological non-union on both plain radiographs and computerised tomography at eight weeks. The bioluminescent bacteria introduced at osteotomy site at time of surgery was also isolated from tissues at the study endpoint, this therefore demonstrated presence of a chronic infection. Use of bioluminescent bacterium allowed for non-invasive real-time monitoring of infection in-vivo. In summary, this thesis has demonstrated the potential for MSCs, or components of their secretome, to be used in the treatment of infected fracture non-union. It also developed a clinically relevant model for use in preclinical studies to investigate and evaluate potential therapeutic strategies for managing infected fracture non-union. Using this model and identifying novel therapies, such as MSCs, could result in reducing the burden of this clinical condition on both the patient and healthcare system treating them.

Degree

thesis:*
Grantor dc:publisher
The University of Edinburgh
Year dc:date.issued
2024

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Robiati, Louise Amy
Advisors dc:contributor.advisor
  • Simpson, Hamish
  • Gallagher, Maurice

Subjects

dc:subject × 5

Rights

Language dc:language.iso
en

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
University of Edinburgh
Base URL
era.ed.ac.uk/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Robiati, Louise Amy. Therapeutic potential of mesenchymal stromal cells for infected fracture non-union. The University of Edinburgh, 2024. https://hdl.handle.net/1842/41983